Friends… I told you these drugs were DANGEROUS…

Now we have proof that semaglutide drugs are literally stealing people’s sight!

A brand-new study just dropped showing that older adults taking semaglutide (the active ingredient in Ozempic and Wegovy) have MORE THAN DOUBLE the risk of developing neovascular age-related macular degeneration—a condition that can leave you permanently blind!

And Big Pharma? They’re staying silent while cashing in on your desperation!

Here are the shocking facts they don’t want you to know:

The study tracked 139,002 patients over 3 years and found that GLP-1 drug users had a 2.21 times higher risk of developing this sight-threatening condition!

But it gets worse…

  • The longer you stay on these drugs, the higher your risk climbs
  • Patients using GLP-1s for more than 30 months had a 62 times higher risk of blindness
  • Even 18-30 months of use more than DOUBLED the risk
  • Semaglutide made up 97.5% of the GLP-1 drugs in this study

And this isn’t the first warning about these drugs destroying your vision!

Previous studies already linked GLP-1 drugs to:

  • Diabetic retinal disease (even though other diabetes symptoms improved!)
  • Nonarteritic ischemic optic neuropathy — another blinding condition
  • Reduced blood flow to the optic nerve

Dr. Brian VanderBeek from the University of Pennsylvania put it perfectly: “There is no such thing as a free lunch” with these medications!

The researchers think they know WHY these drugs are destroying vision: they may trigger dangerous chemical reactions that damage blood vessels in your eyes through something called VEGF production.

Your retina literally becomes starved of oxygen!

But here’s what’s really infuriating…

The medical establishment is calling this a “small” risk because only 0.2% of users developed macular degeneration versus 0.1% of non-users.

SMALL?! We’re talking about your EYESIGHT!

As Dr. Shor, the lead researcher, said: “It’s important to remember that nAMD is a condition with profound implications for vision and quality of life.”

Once you lose your sight to macular degeneration, it’s GONE. There’s no getting it back!

And they knew this was coming! The early clinical trials already showed these drugs were linked to eye problems, but they pushed them through anyway because the money was too good to pass up!

Now millions of people are injecting themselves with these drugs, thinking they’re getting healthier, while their vision slowly deteriorates!

Here’s what you need to know right now:

  • If you’re taking ANY semaglutide drug, demand regular eye exams
  • Ask your doctor about these vision risks (watch them downplay the “small” numbers)
  • Consider natural weight loss methods that don’t threaten your sight
  • Don’t let them dismiss your concerns with statistics

Your vision is irreplaceable. No amount of weight loss is worth going blind!

The study authors admit they need more research to understand the full scope of this problem. Translation: they’re using YOU as guinea pigs while they figure out just how dangerous these drugs really are!

Stop gambling with your eyesight. There are safer ways to lose weight that don’t risk permanent blindness.

Your eyes are worth more than Big Pharma’s profits!

In Your Corner,

Dr. Allan Spreen

In Case You Missed It

Sources:

  • Shor, R., et al. (2025). Risk of Neovascular Age-Related Macular Degeneration Among Patients Using GLP-1 Receptor Agonists. JAMA Ophthalmology.
  • Dotinga, R. (2025, June 5). Semaglutide Linked to Age-Related Macular Degeneration Risk. MedPage Today. https://www.medpagetoday.com/endocrinology/diabetes/116089
  • VanderBeek, B. (2025). Editorial Commentary on GLP-1 Receptor Agonists and Ocular Safety. JAMA Ophthalmology.


Recent Articles:

Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >